Literature DB >> 21383677

Epithelial-mesenchymal transition in prostate cancer: providing new targets for therapy.

Andrew J Armstrong1, Stephen J Freedland, Mariano Garcia-Blanco.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21383677      PMCID： PMC3739204          DOI： 10.1038/aja.2010.169

Source DB:  PubMed          Journal:  Asian J Androl        ISSN： 1008-682X            Impact factor:   3.285


× No keyword cloud information.
  13 in total

Review 1.  Epithelial-mesenchymal transitions in tumour progression.

Authors:  Jean Paul Thiery
Journal:  Nat Rev Cancer       Date:  2002-06       Impact factor: 60.716

2.  Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer.

Authors:  Scott A Tomlins; Bharathi Laxman; Saravana M Dhanasekaran; Beth E Helgeson; Xuhong Cao; David S Morris; Anjana Menon; Xiaojun Jing; Qi Cao; Bo Han; Jindan Yu; Lei Wang; James E Montie; Mark A Rubin; Kenneth J Pienta; Diane Roulston; Rajal B Shah; Sooryanarayana Varambally; Rohit Mehra; Arul M Chinnaiyan
Journal:  Nature       Date:  2007-08-02       Impact factor: 49.962

3.  Repression of E-cadherin by the polycomb group protein EZH2 in cancer.

Authors:  Q Cao; J Yu; S M Dhanasekaran; J H Kim; R-S Mani; S A Tomlins; R Mehra; B Laxman; X Cao; J Yu; C G Kleer; S Varambally; A M Chinnaiyan
Journal:  Oncogene       Date:  2008-09-22       Impact factor: 9.867

4.  Monoclonal antibody targeting of N-cadherin inhibits prostate cancer growth, metastasis and castration resistance.

Authors:  Hiroshi Tanaka; Evelyn Kono; Chau P Tran; Hideyo Miyazaki; Joyce Yamashiro; Tatsuya Shimomura; Ladan Fazli; Robert Wada; Jiaoti Huang; Robert L Vessella; Jaibin An; Steven Horvath; Martin Gleave; Matthew B Rettig; Zev A Wainberg; Robert E Reiter
Journal:  Nat Med       Date:  2010-11-07       Impact factor: 53.440

5.  Cadherin switching in human prostate cancer progression.

Authors:  K Tomita; A van Bokhoven; G J van Leenders; E T Ruijter; C F Jansen; M J Bussemakers; J A Schalken
Journal:  Cancer Res       Date:  2000-07-01       Impact factor: 12.701

6.  N-Cadherin expression in human prostate carcinoma cell lines. An epithelial-mesenchymal transformation mediating adhesion withStromal cells.

Authors:  N L Tran; R B Nagle; A E Cress; R L Heimark
Journal:  Am J Pathol       Date:  1999-09       Impact factor: 4.307

7.  The epithelial-mesenchymal transition generates cells with properties of stem cells.

Authors:  Sendurai A Mani; Wenjun Guo; Mai-Jing Liao; Elinor Ng Eaton; Ayyakkannu Ayyanan; Alicia Y Zhou; Mary Brooks; Ferenc Reinhard; Cheng Cheng Zhang; Michail Shipitsin; Lauren L Campbell; Kornelia Polyak; Cathrin Brisken; Jing Yang; Robert A Weinberg
Journal:  Cell       Date:  2008-05-16       Impact factor: 41.582

Review 8.  The basics of epithelial-mesenchymal transition.

Authors:  Raghu Kalluri; Robert A Weinberg
Journal:  J Clin Invest       Date:  2009-06       Impact factor: 14.808

9.  Identification of selective inhibitors of cancer stem cells by high-throughput screening.

Authors:  Piyush B Gupta; Tamer T Onder; Robert A Weinberg; Eric S Lander; Guozhi Jiang; Kai Tao; Charlotte Kuperwasser
Journal:  Cell       Date:  2009-08-13       Impact factor: 41.582

10.  A switch from E-cadherin to N-cadherin expression indicates epithelial to mesenchymal transition and is of strong and independent importance for the progress of prostate cancer.

Authors:  Karsten Gravdal; Ole J Halvorsen; Svein A Haukaas; Lars A Akslen
Journal:  Clin Cancer Res       Date:  2007-12-01       Impact factor: 12.531
View more
  2 in total

Review 1.  Characteristics of the cancer stem cell niche and therapeutic strategies.

Authors:  Feng Ju; Manar M Atyah; Nellie Horstmann; Sheraz Gul; Razi Vago; Christiane J Bruns; Yue Zhao; Qiong-Zhu Dong; Ning Ren
Journal:  Stem Cell Res Ther       Date:  2022-06-03       Impact factor: 8.079

Review 2.  The osteoblastic and osteoclastic interactions in spinal metastases secondary to prostate cancer.

Authors:  Sathana Dushyanthen; Davina A F Cossigny; Gerald M Y Quan
Journal:  Cancer Growth Metastasis       Date:  2013-11-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.